Clinical Trial: Safety and Efficacy of CC-10004 for Prurigo Nodularis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: An Open Label, Single Center Study to Assess the Safety and Efficacy of a 24 Week Treatment Course of CC-10004 in Adults With Recalcitrant Nodularis
Brief Summary:
This trial will include:
- Study period up to 7 months.
- Office visits monthly lasting approximately 1 hour.
- Blood Draws.
- Oral medication that is taken 2 times daily.
- Photographs and biopsies if agreed.
Detailed Summary:
Sponsor: University Hospitals Cleveland Medical Center
Current Primary Outcome: Improvement in Prurigo Nodularis [ Time Frame: 24 weeks ]
Original Primary Outcome: Determine the effect on patient pruritus as measure by the Visual Analog Scale for Prurtis [ Time Frame: 12 weeks ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University Hospitals Cleveland Medical Center
Dates:
Date Received: March 23, 2009
Date Started: September 2008
Date Completion:
Last Updated: September 27, 2016
Last Verified: September 2016